TP53 and squamous cell lung carcinoma: However, one previous study reported a significant enrichment of Acidovorax in lung squamous cell carcinomas carrying TP53 mutations with a history of smoking, which is inconsistent with our results and may be related to sequencing methods, manipulation, etc. (36).